Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial
EuroIntervention 2017;13:69-77 published online January 2017. DOI: 10.4244/EIJ-D-16-00965
Enrico Fabris1,2, MD; Arnoud van’t Hof1*, MD, PhD; Christian W. Hamm3, MD, PhD; Frédéric Lapostolle4, MD, PhD; Jens Flensted Lassen5, MD, PhD; Shaun G. Goodman6, MD; Jurriën M. ten Berg7, MD, PhD; Leonardo Bolognese8, MD; Angel Cequier9, MD, PhD; Mohamed Chettibi10, MD, PhD; Christopher J. Hammett11, MB, ChB; Kurt Huber12, MD; Magnus Janzon13, MD, PhD; Béla Merkely14, MD, PhD; Robert F. Storey15, MD, DM; Uwe Zeymer16, MD; Warren J. Cantor17, MD; Hélène Rousseau18
1. Cardiology Department, Isala Clinics, Zwolle, the Netherlands; 2. Cardiovascular Department, “Azienda Sanitaria Universitaria Integrata”, University of Trieste, Trieste, Italy; 3. Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany; 4. SAMU 93 Hôpi
Aims: The aim of this study was to identify predictors of complete ST-segment resolution (STR) pre-primary percutaneous coronary intervention (PCI) in patients enrolled in the ATLANTIC tr